Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-05-24 Purchase | 2024-05-28 5:55 pm | OmniAb Inc. | OABI | FOEHR MATTHEW W President and CEO | 240,000 | $4.416 | $1,059,840 | 3,536,665 (Direct) | View |
| 2024-03-22 Purchase | 2024-03-25 07:07 am | OmniAb Inc. | OABI | FOEHR MATTHEW W President and CEO | 225,000 | $5.19 | $1,167,750 | 2,908,803 (Direct) | View |
| 2023-12-12 Purchase | 2023-12-13 3:25 pm | OmniAb Inc. | OABI | FOEHR MATTHEW W Chief Executive Officer | 200,000 | $5.05 | $1,010,000 | 2,645,442 (Direct) | View |
| 2023-11-10 Purchase | 2023-11-13 08:00 am | OmniAb Inc. | OABI | FOEHR MATTHEW W President and CEO | 95,000 | $4.2686 | $405,517 | 2,427,919 (Direct) | View |
| 2023-08-14 Purchase | 2023-08-15 4:56 pm | OmniAb Inc. | OABI | FOEHR MATTHEW W President and CEO | 45,000 | $5.48 | $246,600 | 2,947,487 (Direct) | View |
| 2023-06-09 Purchase | 2023-06-12 4:47 pm | OmniAb Inc. | OABI | FOEHR MATTHEW W Chief Executive Officer | 115,000 | $4.52 | $519,800 | 2,574,009 (Direct) | View |
| 2023-05-12 Purchase | 2023-05-15 4:02 pm | OmniAb Inc. | OABI | FOEHR MATTHEW W Chief Executive Officer | 440,000 | $3.4 | $1,496,000 | 2,438,414 (Direct) | View |
| 2022-12-12 Purchase | 2022-12-14 5:00 pm | OmniAb Inc. | OABI | FOEHR MATTHEW W President & CEO | 150,000 | $3.7651 | $564,765 | 1,838,084 (Direct) | View |
| 2022-11-30 Purchase | 2022-12-01 6:00 pm | OmniAb Inc. | OABI | FOEHR MATTHEW W President & CEO | 300,000 | $3.3878 | $1,016,340 | 1,705,350 (Direct) | View |
| 2022-11-09 Purchase | 2022-11-09 8:30 pm | OmniAb Inc. | OABI | FOEHR MATTHEW W President & CEO | 100,000 | $2.7616 | $276,160 | 1,405,350 (Direct) | View |
| 2022-05-13 Purchase | 2022-05-13 7:05 pm | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO | 2,500 | $82.76 | $206,910 | 173,354 (Direct) | View |
| 2022-05-02 Purchase | 2022-05-03 4:12 pm | Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director | 45,000 | $2.471 | $111,195 | 111,250 (Direct) | View |
| 2021-11-11 Sale | 2021-11-12 4:54 pm | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO | 11,160 | $163.02 | $1,819,255 | 190,873 (Direct) | View |
| 2021-08-04 Sale | 2021-08-05 4:44 pm | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO | 8,840 | $109.67 | $969,507 | 202,595 (Direct) | View |
| 2021-06-10 Purchase | 2021-06-10 4:57 pm | Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director | 20,000 | $5.69 | $113,800 | 66,250 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-27 Exercise | 2024-06-27 4:55 pm | N/A 2032-12-07 | OmniAb Inc. | OABI | FOEHR MATTHEW W President and CEO | 59,659 | $0 | 4,250,455 (Direct) | View |
| 2024-06-27 Exercise | 2024-06-27 4:55 pm | N/A N/A | OmniAb Inc. | OABI | FOEHR MATTHEW W President and CEO | 41,015 | $3.75 | 4,250,455 (Direct) | View |
| 2024-06-27 Exercise | 2024-06-27 4:55 pm | N/A N/A | OmniAb Inc. | OABI | FOEHR MATTHEW W President and CEO | 18,644 | $3.68 | 4,250,455 (Direct) | View |
| 2022-11-01 Option Award(A) | 2024-04-23 5:44 pm | N/A N/A | OmniAb Inc. | OABI | FOEHR MATTHEW W President and CEO | 1,431,618 | $0 | 3,296,665 (Direct) | View |
| 2024-04-07 Exercise | 2024-04-09 6:38 pm | N/A N/A | OmniAb Inc. | OABI | FOEHR MATTHEW W President and CEO | 36,458 | $0 | 3,432,347 (Direct) | View |
| 2024-04-07 Tax Withholding | 2024-04-09 6:38 pm | N/A N/A | OmniAb Inc. | OABI | FOEHR MATTHEW W President and CEO | 18,477 | $5.31 | 3,432,347 (Direct) | View |
| 2024-03-27 Exercise | 2024-03-29 4:52 pm | N/A 2032-12-07 | OmniAb Inc. | OABI | FOEHR MATTHEW W President and CEO | 243,613 | $0 | 3,863,364 (Direct) | View |
| 2024-03-27 Exercise | 2024-03-29 4:52 pm | N/A N/A | OmniAb Inc. | OABI | FOEHR MATTHEW W President and CEO | 150,391 | $3.75 | 3,863,364 (Direct) | View |
| 2024-03-27 Exercise | 2024-03-29 4:52 pm | N/A N/A | OmniAb Inc. | OABI | FOEHR MATTHEW W President and CEO | 93,222 | $3.68 | 3,863,364 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-20 6:22 pm | N/A N/A | OmniAb Inc. | OABI | FOEHR MATTHEW W Chief Executive Officer | 37,328 | $0 | 4,043,085 (Direct) | View |
| 2024-02-15 Tax Withholding | 2024-02-20 6:22 pm | N/A N/A | OmniAb Inc. | OABI | FOEHR MATTHEW W Chief Executive Officer | 18,919 | $5.54 | 4,043,085 (Direct) | View |
| 2024-02-16 Option Award | 2024-02-20 6:22 pm | N/A N/A | OmniAb Inc. | OABI | FOEHR MATTHEW W Chief Executive Officer | 765,625 | $0 | 4,043,085 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 9:22 pm | 2025-01-02 2034-01-02 | Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2024-01-02 Exercise | 2024-01-03 5:42 pm | N/A N/A | OmniAb Inc. | OABI | FOEHR MATTHEW W Chief Executive Officer | 33,173 | $0 | 2,891,755 (Direct) | View |
| 2024-01-02 Tax Withholding | 2024-01-03 5:42 pm | N/A N/A | OmniAb Inc. | OABI | FOEHR MATTHEW W Chief Executive Officer | 13,221 | $6.25 | 2,891,755 (Direct) | View |
| 2023-12-07 Exercise | 2023-12-11 7:24 pm | N/A N/A | OmniAb Inc. | OABI | FOEHR MATTHEW W Chief Executive Officer | 26,556 | $0 | 2,704,976 (Direct) | View |
| 2023-12-07 Tax Withholding | 2023-12-11 7:24 pm | N/A N/A | OmniAb Inc. | OABI | FOEHR MATTHEW W Chief Executive Officer | 9,184 | $4.85 | 2,704,976 (Direct) | View |
| 2023-04-07 Option Award | 2023-04-11 7:11 pm | N/A 2033-04-07 | OmniAb Inc. | OABI | FOEHR MATTHEW W Chief Executive Officer | 765,625 | $0 | 2,654,664 (Direct) | View |
| 2023-02-15 Tax Withholding | 2023-02-17 7:28 pm | N/A N/A | OmniAb Inc. | OABI | FOEHR MATTHEW W President & CEO | 17,086 | $3.8 | 1,889,039 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 5:05 pm | N/A N/A | OmniAb Inc. | OABI | FOEHR MATTHEW W President & CEO | 79,665 | $0 | 1,906,125 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 6:03 pm | 2024-01-03 2033-01-03 | Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2022-12-28 Tax Withholding | 2022-12-30 5:00 pm | N/A N/A | OmniAb Inc. | OABI | FOEHR MATTHEW W President & CEO | 11,624 | $3.66 | 1,826,460 (Direct) | View |
| 2022-12-07 Option Award | 2022-12-09 6:00 pm | N/A 2032-12-07 | OmniAb Inc. | OABI | FOEHR MATTHEW W President & CEO | 298,311 | $0 | 298,311 (Direct) | View |
| 2022-12-01 Tax Withholding | 2022-12-05 9:36 pm | N/A N/A | OmniAb Inc. | OABI | FOEHR MATTHEW W President & CEO | 17,266 | $3.35 | 1,688,084 (Direct) | View |
| 2022-11-01 Option Award | 2022-11-03 9:10 pm | N/A 2024-02-12 | OmniAb Inc. | OABI | FOEHR MATTHEW W President & CEO | 2,693,809 | $0 | 2,693,809 (Direct) | View |
| 2022-11-01 Disposition | 2022-11-03 9:10 pm | N/A 2032-05-05 | OmniAb Operations Inc. | FOEHR MATTHEW W CLO & Secretary | 495,710 | $0 | 60,878 (Direct) | View | |
| 2022-11-01 Option Award | 2022-11-03 9:10 pm | N/A 2032-05-05 | OmniAb Operations Inc. | FOEHR MATTHEW W CLO & Secretary | 87,071 | $0 | 60,878 (Direct) | View | |
| 2022-11-01 Disposition | 2022-11-03 9:06 pm | N/A 2032-05-05 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W Former Executive Officer | 54,518 | $0 | 162,187 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 5:55 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO | 9,137 | $0 | 182,491 (Direct) | View |
| 2022-05-05 Option Award | 2022-05-09 8:10 pm | N/A 2032-05-05 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO | 34,214 | $0 | 34,214 (Direct) | View |
| 2022-02-15 Tax Withholding | 2022-02-16 8:24 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO | 3,546 | $123.68 | 170,854 (Direct) | View |
| 2022-01-26 Tax Withholding | 2022-01-28 8:41 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO | 5,125 | $113.68 | 174,400 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 8:41 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO | 13,000 | $0 | 174,400 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 7:08 pm | 2023-01-03 2032-01-03 | Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2021-11-11 Exercise | 2021-11-12 4:54 pm | N/A 2023-02-15 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO | 12,188 | $0 | 190,873 (Direct) | View |
| 2021-11-11 Exercise | 2021-11-12 4:54 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO | 1,028 | $100.38 | 190,873 (Direct) | View |
| 2021-11-11 Exercise | 2021-11-12 4:54 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO | 11,160 | $21.92 | 190,873 (Direct) | View |
| 2021-08-04 Exercise | 2021-08-05 4:44 pm | N/A 2023-02-15 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO | 9,982 | $0 | 202,595 (Direct) | View |
| 2021-08-04 Exercise | 2021-08-05 4:44 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO | 8,840 | $21.92 | 202,595 (Direct) | View |
| 2021-08-04 Exercise | 2021-08-05 4:44 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO | 1,142 | $85.79 | 202,595 (Direct) | View |